Gili Kenet

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Journal of clinical medicine

British journal of haematology

Blood

Sheba Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sheba Medical Center Jul 01 2013

Israel

Director :: NATIONAL HEMOPHILIA CENTER

Publications

Sanjay Ahuja, Tina T Biss, Monika Maas Enriquez, Maria Elisa Mancuso, MacGregor Steele, Gili Kenet
A post hoc analysis of PROTECT VIII kids assessing long-term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A. European journal of haematology 112 (5) (2024)
Sarina Levy-Mendelovich, Noa Greenberg-Kushnir, Ivan Budnik, Assaf Arie Barg, Omri Cohen, Einat Avishai, Tami Barazani-Brutman, Tami Livnat, Gili Kenet
Emicizumab prophylaxis in infants: Single-centre experience. British journal of haematology 204 (4) (2024)
Assaf Arie Barg, Tami Livnat, Gili Kenet
Factor XI deficiency: phenotypic age-related considerations and clinical approach towards bleeding risk assessment. Blood 143 (15) (2024)
Sanjay Ahuja, Tina T Biss, Monika Maas Enriquez, Maria Elisa Mancuso, MacGregor Steele, Gili Kenet
A post hoc analysis of PROTECT VIII kids assessing long-term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A. European journal of haematology (2024)
Sarina Levy-Mendelovich, Noa Greenberg-Kushnir, Ivan Budnik, Assaf Arie Barg, Omri Cohen, Einat Avishai, Tami Barazani-Brutman, Tami Livnat, Gili Kenet
Emicizumab prophylaxis in infants: Single-centre experience. British journal of haematology 204 (4) (2024)
Sarina Levy-Mendelovich, Noa Greenberg-Kushnir, Ivan Budnik, Assaf Arie Barg, Omri Cohen, Einat Avishai, Tami Barazani-Brutman, Tami Livnat, Gili Kenet
Emicizumab prophylaxis in infants: Single-centre experience. British journal of haematology (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood 143 (22) (2024)
Sanjay Ahuja, Tina T Biss, Monika Maas Enriquez, Maria Elisa Mancuso, MacGregor Steele, Gili Kenet
A post hoc analysis of PROTECT VIII kids assessing long-term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A. European journal of haematology 112 (5) (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood 143 (22) (2024)
Gili Kenet, Beatrice Nolan, Osman Bülent Zülfikar, Ali Bülent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N Bagot, Azizan Sharif, Flora Peyvandi, Guy Aaron Young, Claude G Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Andersson, Kaan Kavakli
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood 143 (22) (2024)
Susan Halimeh, Lydia Koch, Gili Kenet, Piotr Kuta, Tess Rahmfeld, Monika Stoll, Ulrike Nowak-Göttl
Genotype-Phenotype Relationship among 785 Unrelated White Women with Inherited Congenital Factor VII Deficiency: A Three-Center Database Study. Journal of clinical medicine 13 (1) (2023)
Rima Dardik, Szymon Janczar, Shadan Lalezari, Einat Avishai, Sarina Levy-Mendelovich, Assaf Arie Barg, Uri Martinowitz, Katarzyna Bąbol-Pokora, Wojciech Mlynarski, Gili Kenet
Four Decades of Carrier Detection and Prenatal Diagnosis in Hemophilia A: Historical Overview, State of the Art and Future Directions. International journal of molecular sciences 24 (14) (2023)
Susan Halimeh, Lydia Koch, Gili Kenet, Piotr Kuta, Tess Rahmfeld, Monika Stoll, Ulrike Nowak-Göttl
Genotype-Phenotype Relationship among 785 Unrelated White Women with Inherited Congenital Factor VII Deficiency: A Three-Center Database Study. Journal of clinical medicine 13 (1) (2023)
Yehonatan Weinberger, Ivan Budnik, Yael Nisgav, Dahlia Palevski, Gil Ben-David, Jose A Fernandez, Shany Nivinsky Margalit, Sarina Levy-Mendelovich, Gili Kenet, Dov Weinberger, John H Griffin, Tami Livnat
3K3A-Activated Protein C Inhibits Choroidal Neovascularization Growth and Leakage and Reduces NLRP3 Inflammasome, IL-1β, and Inflammatory Cell Accumulation in the Retina. International journal of molecular sciences 24 (13) (2023)
Eyal Klang, Gili Kenet, Sarina Levy-Mendelovich
Most impactful COVID-19 articles in the field of thrombosis and hemostasis literature. Journal of thrombosis and haemostasis : JTH 20 (11) (2022)
Victor Jimenez Yuste, Flora Peyvandi, Robert Klamroth, Giancarlo Castaman, Chandrakala Shanmukhaiah, Savita Rangarajan, Jaime García Chavez, Raul Martinez, Gili Kenet, Hazaa Alzahrani, Susan Robson, Christophe Schmitt, Anna Kiialainen, Oliver Meier, Margareth Ozelo
Safety and efficacy of long-term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: A phase 3b, multicenter, single-arm study (STASEY). Research and practice in thrombosis and haemostasis 6 (8) (2022)
Dahlia Palevski, Gil Ben-David, Yehonatan Weinberger, Rabeei Haj Daood, Jose A Fernandez, Ivan Budnik, Sarina Levy-Mendelovich, Gili Kenet, Yael Nisgav, Dov Weinberger, John H Griffin, Tami Livnat
3K3A-Activated Protein C Prevents Microglia Activation, Inhibits NLRP3 Inflammasome and Limits Ocular Inflammation. International journal of molecular sciences 23 (22) (2022)
Dimitra Gialamprinou, Georgios Mitsiakos, Georgios Ν Katsaras, Christos-Georgios Kontovazainitis, Paraskevi Karagianni, Emmanuel Roilides, Gili Kenet
Neonatal Sepsis and Hemostasis. Diagnostics (Basel, Switzerland) 12 (2) (2022)
Sarina Levy-Mendelovich, Tami Brutman-Barazani, Ivan Budnik, Einat Avishai, Assaf A Barg, Tamara Levy, Mudi Misgav, Tami Livnat, Gili Kenet
Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab. Journal of clinical medicine 10 (19) (2021)
Assaf A Barg, Ivan Budnik, Einat Avishai, Tami Brutman-Barazani, Dalia Bashari, Mudi Misgav, Aaron Lubetsky, Amir A Kuperman, Tami Livnat, Gili Kenet
Emicizumab prophylaxis: Prospective longitudinal real-world follow-up and monitoring. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)
Maria Elisa Mancuso, Tina Biss, Kathelijn Fischer, Monika Maas Enriquez, MacGregor Steele, Maria Wang, Despina Tseneklidou-Stoeter, Sanjay Ahuja, Gili Kenet
PROTECT VIII kids extension study: Long-term safety and efficacy of BAY 94-9027 (damoctocog alfa pegol) in children with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)
Gili Kenet, Yeu-Chin Chen, Gillian Lowe, Charles Percy, Huyen Tran, Annette von Drygalski, Marc Trossaërt, Mark Reding, Johannes Oldenburg, Maria-Eva Mingot-Castellano, Young-Shil Park, Flora Peyvandi, Margareth C Ozelo, Johnny Mahlangu, Jennifer Quinn, Mei Huang, Divya B Reddy, Benjamin Kim
Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study. Journal of clinical medicine 10 (24) (2021)
Mudi Misgav, Tami Brutman-Barazani, Ivan Budnik, Einat Avishai, Jonathan Schapiro, Dalia Bashari, Assaf A Barg, Aaron Lubetsky, Tami Livnat, Gili Kenet
Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real-world data. Haemophilia : the official journal of the World Federation of Hemophilia 27 (2) (2021)
Alexander Solms, Shadan Lalezari, Anita Shah, Gili Kenet
Population pharmacokinetic (PopPK) modelling indicates that patients switching to BAY 81-8973 from rFVIII-FS can continue their dosing schedule with improved protection. Haemophilia : the official journal of the World Federation of Hemophilia 26 (3) (2020)
Maria Elisa Mancuso, Johannes Oldenburg, Lisa Boggio, Gili Kenet, Anthony Chan, Carmen Altisent, Wilfried Seifert, Elena Santagostino
High adherence to prophylaxis regimens in haemophilia B patients receiving rIX-FP: Evidence from clinical trials and real-world practice. Haemophilia : the official journal of the World Federation of Hemophilia 26 (4) (2020)
Assaf Arie Barg, Tami Livnat, Ivan Budnik, Einat Avishai, Tami Brutman-Barazani, Ilia Tamarin, Dalia Bashari, Mudi Misgav, Gili Kenet
Emicizumab treatment and monitoring in a paediatric cohort: real-world data. British journal of haematology 191 (2) (2020)
Elena Santagostino, Gili Kenet, Kathelijn Fischer, Tina Biss, Sanjay Ahuja, MacGregor Steele
PROTECT VIII Kids: BAY 94-9027 (PEGylated Recombinant Factor VIII) safety and efficacy in previously treated children with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 26 (3) (2020)
Sylvia von Mackensen, Jinesh Shah, Wilfried Seifert, Gili Kenet
Health-related quality of life in paediatric haemophilia B patients treated with rIX-FP. Haemophilia : the official journal of the World Federation of Hemophilia 25 (1) (2018)

Gili Kenet.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gili Kenet